Webull's National Security Risk Adds New Overhang to Already-Weakened Investment Thesis

What happened

A bipartisan congressional committee has concluded that trading platform Webull is 'structurally' linked to the Chinese government, presenting a national security risk. This finding introduces a new regulatory and political risk that was not factored into the prior investment thesis, which already flagged concerns around PFOF dependence and spending discipline. The House Select Committee on China's report, shared with CNBC, could prompt further scrutiny from US regulators, potentially affecting Webull's ability to operate or expand in its largest market. While Webull's balance sheet remains liquid with $653 million in cash against $65 million in notes, the new risk compounds existing uncertainties around growth sustainability and monetization. Investors should now discount the probability of near-term multiple expansion, as the stock is likely to remain under pressure until the national security concerns are resolved or disproven.

Implication

The congressional finding is a serious development that could lead to executive orders, CFIUS reviews, or restrictions on Webull's US operations, which generate the majority of revenue. Previous risks (PFOF concentration, slowing deposits) remain, but the national security issue dwarfs them in severity because it threatens the core business license. Even if no immediate action is taken, the overhang will depress valuation multiples, and the company may face customer attrition and partner reluctance. The existing WAIT rating, with a $6 attractive entry, should be revised lower or suspended until the political situation clarifies; the trim level of $9.50 is now unreachable in the near term. For contrarian investors, any resolution that clears Webull of the security concerns could lead to a sharp rebound, but the probability of that is low in the next 3-6 months.

Thesis delta

The prior WAIT thesis assumed regulatory risk was limited to PFOF and market-structure changes; the congressional national security finding now introduces a potential categorical ban or operational restriction that was not previously considered. This shifts the risk/reward materially to the downside, invalidating the $6 attractive entry and requiring a re-assessment of the base case probability. Until the company can convincingly address these allegations, we would lower our rating to SELL/AVOID for non-speculative investors.